Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies

[1]  J. Tuomilehto,et al.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.

[2]  L. Bouter,et al.  Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study , 1996, Diabetologia.

[3]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[4]  P. Ducimetiere,et al.  Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population , 1980, Diabetologia.

[5]  A. Rosengren,et al.  Insulin resistance and other risk factors for coronary heart disease in elderly men. The Study of Men Born in 1913 and 1923 , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[6]  G. Hu,et al.  Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes , 2003, Diabetologia.

[7]  K. Eriksson,et al.  Hyperinsulinaemia as long‐term predictor of death and ischaemic heart disease in nondiabetic men: The Malmö Preventive Project , 2003, Journal of internal medicine.

[8]  S. Haffner,et al.  Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. , 2002, Diabetes care.

[9]  P. Nilsson,et al.  Insulin resistance in non‐diabetic subjects is associated with increased incidence of myocardial infarction and death , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[10]  C. Berne,et al.  Proinsulin Is an Independent Predictor of Coronary Heart Disease: Report From a 27-Year Follow-Up Study , 2002, Circulation.

[11]  B. Zethelius.  Proinsulin and Insulin Sensitivity as Predictors of Type 2 Diabetes Mellitus and Coronary Heart Disease : Clinical Epidemiological Studies with up to 27 Years of Follow-Up , 2002 .

[12]  P. Elwood,et al.  Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study , 2002, Diabetologia.

[13]  R. Walker,et al.  Diagnosing insulin resistance in the general population. , 2001, Diabetes care.

[14]  E. Feskens,et al.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.

[15]  M. Laakso,et al.  Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study. , 2000, Diabetes care.

[16]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[17]  T. Lakka,et al.  Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2000, Archives of internal medicine.

[18]  G. Reaven,et al.  Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. , 2000, Diabetes care.

[19]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[20]  G. Hallmans,et al.  High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. , 1999, Metabolism: clinical and experimental.

[21]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[22]  R. Collins,et al.  Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.

[23]  M. Laakso,et al.  Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. , 1999, Circulation.

[24]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[25]  J. Tuomilehto,et al.  Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies , 1999 .

[26]  T. T. 1. D. T. S. Group,et al.  Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies , 1999, Diabetologia.

[27]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[28]  H. Lithell,et al.  Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data , 1998 .

[29]  M. Laakso,et al.  Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. , 1998, Circulation.

[30]  G. Reaven,et al.  Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. , 1998, The Journal of clinical endocrinology and metabolism.

[31]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[32]  L. Bouter,et al.  Insulin and risk of cardiovascular disease: a meta-analysis. , 1998, Circulation.

[33]  P. Bennett,et al.  Intact Proinsulin, des 31,32 Proinsulin, and Specific Insulin Concentrations Among Nondiabetic and Diabetic Subjects in Populations at Varying Risk of Type 2 Diabetes , 1998, Diabetes Care.

[34]  S. Haffner,et al.  Development of the multiple metabolic syndrome: an epidemiologic perspective. , 1998, Epidemiologic reviews.

[35]  R N Bergman,et al.  Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. , 1997, American journal of epidemiology.

[36]  M. Alessi,et al.  PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events , 1997, Thrombosis and Haemostasis.

[37]  A. Folsom,et al.  A Prospective Study of Coronary Heart Disease in Relation to Fasting Insulin, Glucose, and Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study , 1997, Diabetes Care.

[38]  T. Strandberg,et al.  Elevated Fasting Plasma Insulin in a General Aged Population: An Innocent Companion of Cardiovascular Diseases , 1997, Journal of the American Geriatrics Society.

[39]  S. Stender,et al.  Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits , 1997, Diabetologia.

[40]  G. Reaven.  Banting lecture 1988 , 1997 .

[41]  P. Whincup,et al.  Serum insulin and incident coronary heart disease in middle-aged British men. , 1996, American journal of epidemiology.

[42]  R. Bergman,et al.  Insulin Sensitivity and Atherosclerosis , 1996 .

[43]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[44]  K. Polonsky,et al.  Report of the American Diabetes Association's Task Force on Standardization of the Insulin Assay , 1996, Diabetes.

[45]  R. Bergman,et al.  Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. , 1996, Circulation.

[46]  BjörnFagerberg,et al.  Carotid Artery Wall Intima-Media Thickness Is Associated With Insulin-Mediated Glucose Disposal in Men at High and Low Coronary Risk , 1995 .

[47]  J. Jespersen,et al.  Fasting Serum Insulin Levels and Coronary Heart Disease in a Danish Cohort: 17-year Follow-up , 1995, Journal of cardiovascular risk.

[48]  B. Fagerberg,et al.  Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. , 1995, Stroke.

[49]  E. Barrett-Connor,et al.  Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. , 1994, American journal of epidemiology.

[50]  J. Yarnell,et al.  Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. , 1994, British heart journal.

[51]  L. Kuller,et al.  Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. , 1994, Annals of epidemiology.

[52]  J. Tuomilehto,et al.  Serum insulin and ECG abnormalities suggesting coronary heart disease in the populations of Mauritius and Nauru: cross-sectional and longitudinal associations. , 1993, Journal of clinical epidemiology.

[53]  J. Fleiss.  Review papers : The statistical basis of meta-analysis , 1993 .

[54]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[55]  J. Fleiss,et al.  The statistical basis of meta-analysis. , 1993, Statistical methods in medical research.

[56]  M. Laakso,et al.  Asymptomatic atherosclerosis and insulin resistance. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[57]  R. Stout,et al.  Insulin and atheroma. 20-yr perspective. , 1990, Diabetes care.

[58]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[59]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[60]  Y. Oshida,et al.  Experimental Atherosclerosis-Like Lesions Induced by Hyperinsulinism in Wistar Rats , 1989, Diabetes.

[61]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[62]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[63]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[64]  K. Pyörälä.  Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland , 1979, Diabetes Care.

[65]  T. Welborn,et al.  Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations , 1979, Diabetes Care.

[66]  G. Knatterud,et al.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. , 1978, JAMA.

[67]  C. Meinert,et al.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results. , 1971, JAMA.

[68]  R. Stout,et al.  Insulin and atheroma. , 1969, Lancet.